Consolidated Statements of Equity - USD ($) $ in Thousands	Total	Preferred Shares	Common Shares	Additional Paid-In Capital	Additional Paid-In Capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Income (Loss)	Distributions in Excess of Retained Earnings	Total Shareholders' Equity	Total Shareholders' Equity Cumulative Effect, Period of Adoption, Adjustment	Non-Controlling Interests
Preferred stock, beginning balance (in shares) at Dec. 31, 2020		20,400,000
Common shares, beginning balance (in shares) at Dec. 31, 2020			130,673,300
Beginning balance at Dec. 31, 2020	$ 3,264,326	$ 204	$ 1,307	$ 4,169,870	$ (113,099)	$ (60,071)	$ (853,973)	$ 3,257,337	$ (113,099)	$ 6,989
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of shares, net of offering costs (in shares)		9,200,000
Issuance of shares, net of offering costs	222,330	$ 92		222,238				222,330
Issuance of common shares for Board of Trustees compensation (in shares)			27,711
Issuance of common shares for Board of Trustees compensation	516		$ 1	515				516
Repurchase of common shares (in shares)			(38,310)
Repurchase of common shares	(720)		$ (1)	(719)				(720)
Share-based compensation (in shares)			151,049
Share-based compensation	6,691		$ 1	5,643				5,644		1,047
Distributions on common shares/units	(2,429)						(2,396)	(2,396)		(33)
Distributions on preferred shares/units	(18,233)						(18,233)	(18,233)
Purchases of capped calls in connection with convertible senior notes				(20,975)				(20,975)
Other comprehensive income (loss):
Change in fair value of derivative instruments	7,426					7,426		7,426
Amounts reclassified from other comprehensive income	12,825					12,825		12,825
Net income (loss)	(120,012)						(119,052)	(119,052)		(960)
Common shares, ending balance (in shares) at Jun. 30, 2021			130,813,750
Preferred stock, ending balance (in shares) at Jun. 30, 2021		29,600,000
Ending balance at Jun. 30, 2021	3,238,646	$ 296	$ 1,308	4,263,473		(39,820)	(993,654)	3,231,603		7,043
Preferred stock, beginning balance (in shares) at Mar. 31, 2021		20,400,000
Common shares, beginning balance (in shares) at Mar. 31, 2021			130,812,917
Beginning balance at Mar. 31, 2021	3,019,156	$ 204	$ 1,308	4,038,860		(43,917)	(983,771)	3,012,684		6,472
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of shares, net of offering costs (in shares)		9,200,000
Issuance of shares, net of offering costs	222,340	$ 92		222,248				222,340
Share-based compensation (in shares)			833
Share-based compensation	3,063			2,365				2,365		698
Distributions on common shares/units	(1,344)						(1,319)	(1,319)		(25)
Distributions on preferred shares/units	(10,094)						(10,094)	(10,094)
Other comprehensive income (loss):
Change in fair value of derivative instruments	(2,310)					(2,310)		(2,310)
Amounts reclassified from other comprehensive income	6,407					6,407		6,407
Net income (loss)	1,428						1,530	1,530		(102)
Common shares, ending balance (in shares) at Jun. 30, 2021			130,813,750
Preferred stock, ending balance (in shares) at Jun. 30, 2021		29,600,000
Ending balance at Jun. 30, 2021	$ 3,238,646	$ 296	$ 1,308	4,263,473		(39,820)	(993,654)	3,231,603		7,043
Preferred stock, beginning balance (in shares) at Dec. 31, 2021	29,600,000	29,600,000
Common shares, beginning balance (in shares) at Dec. 31, 2021	130,813,750		130,813,750
Beginning balance at Dec. 31, 2021	$ 3,163,905	$ 296	$ 1,308	4,268,042		(19,442)	(1,094,023)	3,156,181		7,724
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of shares, net of offering costs	(75)			(75)				(75)
Issuance of operating partnership units	78,000									78,000
Issuance of common shares for Board of Trustees compensation (in shares)			33,866
Issuance of common shares for Board of Trustees compensation	738		$ 1	737				738
Repurchase of common shares (in shares)			(49,787)
Repurchase of common shares	(1,113)		$ (1)	(1,112)				(1,113)
Share-based compensation (in shares)			107,303
Share-based compensation	4,974		$ 1	3,577				3,578		1,396
Distributions on common shares/units	(2,475)						(2,442)	(2,442)		(33)
Distributions on preferred shares/units	(23,334)						(22,687)	(22,687)		(647)
Other comprehensive income (loss):
Change in fair value of derivative instruments	36,697					36,412		36,412		285
Amounts reclassified from other comprehensive income	6,778					6,778		6,778
Net income (loss)	$ (71,419)						(71,541)	(71,541)		122
Common shares, ending balance (in shares) at Jun. 30, 2022	130,905,132		130,905,132
Preferred stock, ending balance (in shares) at Jun. 30, 2022	29,600,000	29,600,000
Ending balance at Jun. 30, 2022	$ 3,192,676	$ 296	$ 1,309	4,271,169		23,748	(1,190,693)	3,105,829		86,847
Preferred stock, beginning balance (in shares) at Mar. 31, 2022		29,600,000
Common shares, beginning balance (in shares) at Mar. 31, 2022			130,904,299
Beginning balance at Mar. 31, 2022	3,084,934	$ 296	$ 1,309	4,269,322		12,092	(1,206,019)	3,077,000		7,934
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of shares, net of offering costs	(75)			(75)				(75)
Issuance of operating partnership units	78,000									78,000
Share-based compensation (in shares)			833
Share-based compensation	2,620			1,922				1,922		698
Distributions on common shares/units	(1,344)						(1,320)	(1,320)		(24)
Distributions on preferred shares/units	(11,990)						(11,343)	(11,343)		(647)
Other comprehensive income (loss):
Change in fair value of derivative instruments	9,330					9,252		9,252		78
Amounts reclassified from other comprehensive income	2,404					2,404		2,404
Net income (loss)	$ 28,797						27,989	27,989		808
Common shares, ending balance (in shares) at Jun. 30, 2022	130,905,132		130,905,132
Preferred stock, ending balance (in shares) at Jun. 30, 2022	29,600,000	29,600,000
Ending balance at Jun. 30, 2022	$ 3,192,676	$ 296	$ 1,309	$ 4,271,169		$ 23,748	$ (1,190,693)	$ 3,105,829		$ 86,847